|
|
Volumn 22, Issue 5, 2016, Pages 450-451
|
|
Foretelling toxicity: FDA researchers work to predict risk of liver injury from drugs
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DASABUVIR PLUS OMBITASVIR PLUS PARITAPREVIR PLUS RITONAVIR;
DRUG;
ANTIVIRAL THERAPY;
COMPUTER MODEL;
DIGESTIVE SYSTEM DISEASE ASSESSMENT;
DRUG INDUCED LIVER INJURY SCORE;
DRUG INDUSTRY;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
HEPATITIS C;
HUMAN;
NONHUMAN;
NOTE;
PREDICTIVE VALUE;
PRIORITY JOURNAL;
QUALITY CONTROL;
RISK ASSESSMENT;
TOXIC HEPATITIS;
CHEMICALLY INDUCED;
COMPLICATION;
COMPUTER SIMULATION;
DRUG APPROVAL;
DRUG EFFECTS;
HEPACIVIRUS;
LIVER FAILURE;
PATHOGENICITY;
PATHOLOGY;
THEORETICAL MODEL;
UNITED STATES;
VIROLOGY;
CHEMICAL AND DRUG INDUCED LIVER INJURY;
COMPUTER SIMULATION;
DRUG APPROVAL;
HEPACIVIRUS;
HEPATITIS C;
HUMANS;
LIVER FAILURE;
MODELS, THEORETICAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84966343999
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0516-450 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
